By Julie Steenhuysen CHICAGO (Reuters) - A new way of evaluating tumors may soon help cancer patients identify the underlying genetic link to their disease - and the best possible treatment – all in a single test. Researchers are set to begin clinical trials using a more comprehensive testing method that looks for all of the known genes that may be active in a tumor. The new method could guide patients to the right drug earlier, potentially replacing current tests known as...
Full Story: Baltimore Sun
